Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
A new vial at 5 mg/mL instead of 10 mg/mL means your 50 units now delivers 2.5 mg instead of 5 mg, cutting your effective dose in half
Lancet 392:15191529 Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydn L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T (2019) REWIND Investigators
The FDA provided positive end-of-Phase 2 feedback, and Phase 3 initiation is on track for the third quarter of 2026
That is, the reaction rate is "diffusion-limited"
US$ 24.18
US$ 29.62
US$ 21.42
US$ 26.58
US$ 26.99
US$ 29.25
US$ 29.56
